Related references
Note: Only part of the references are listed.Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
Jacob Lonborg et al.
EUROPEAN HEART JOURNAL (2012)
Mechanisms for the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes
Elza Muscelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control
P. Anagnostis et al.
DIABETES OBESITY & METABOLISM (2011)
Effect of sitagliptin plus metformin on β-cell function, islet integrity and islet gene expression in Zucker diabetic fatty rats
Seung Jin Han et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Sitagliptin: a review
Sreevidya Subbarayan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Preservation of β-Cell Function: The Key to Diabetes Prevention
Ralph A. DeFronzo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Pathophysiology of Prediabetes
Ele Ferrannini et al.
MEDICAL CLINICS OF NORTH AMERICA (2011)
Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
Yuji Ishibashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes
Debora Williams-Herman et al.
BMC ENDOCRINE DISORDERS (2010)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
Leo Timmers et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A Position Statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Glucometrics in patients hospitalized with acute myocardial infarction
Mikhail Kosiborod et al.
CIRCULATION (2008)
Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction
Koichi Tamita et al.
CIRCULATION JOURNAL (2007)
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease:: a report from the Euro Heart Survey on diabetes and the heart
Mattie Lenzen et al.
EUROPEAN HEART JOURNAL (2006)
The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey
Da-Yi Hu et al.
EUROPEAN HEART JOURNAL (2006)
Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes
James Mu et al.
DIABETES (2006)
Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts
Tingcun Zhao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes:: a report from the GAMI study
M Wallander et al.
DIABETOLOGIA (2005)
Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism
T Nyström et al.
REGULATORY PEPTIDES (2005)
Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin
T Nakagami
DIABETOLOGIA (2004)
The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe -: The Euro Heart Survey on diabetes and the heart
M Bartnik et al.
EUROPEAN HEART JOURNAL (2004)
Newly detected abnormal glucose tolerance:: an important predictor of long-term outcome after myocardial infarction
M Bartnik et al.
EUROPEAN HEART JOURNAL (2004)
Abnormal glucose tolerance -: a common risk factor in patients with acute myocardial infarction in comparison with population-based controls
M Bartnik et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets
L Farilla et al.
ENDOCRINOLOGY (2003)
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:: a prospective study
A Norhammar et al.
LANCET (2002)
The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus
RE Pratley et al.
DIABETOLOGIA (2001)
Glucose tolerance and cardiovascular mortality -: Comparison of fasting and 2-hour diagnostic criteria
K Borch-Johnsen et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
JS Alpert et al.
EUROPEAN HEART JOURNAL (2000)
Share Paper
